马方综合征与非马方综合征患者接受胸腹主动脉瘤修复术的风险特征与手术结局
该研究纳入1997年至2022年连续接受开放性胸腹主动脉瘤修复术的684例患者,其中马方综合征90例(13.1%),非马方综合征594例(86.9%)。马方综合征患者更年轻,Extent II或III型动脉瘤及I或III型慢性夹层更常见,但心血管危险因素较少。两组主要不良事件和手术死亡率无显著差异,加权分析显示长期生存无差异,马方综合征并非主要不良事件的独立相关因素。
要点
- 马方综合征患者接受开放性胸腹主动脉瘤修复术的主要不良事件发生率与非马方综合征患者无显著差异(13.3% vs 16.8%,P=.49)。
- 马方综合征患者手术死亡率与非马方综合征患者相似(3.3% vs 4.7%,P=.75),加权后长期生存无差异(校正HR 0.79,95%CI 0.32-1.99,P=.62)。
- 肾功能不全(OR 2.29,95%CI 1.43-3.68,P<.01)和急诊/紧急手术(OR 2.17,95%CI 1.35-3.48,P<.01)与主要不良事件相关,而马方综合征不是(OR 1.56,95%CI 0.69-3.49,P=.28)。
核心结论
- 尽管风险特征不同,马方综合征与非马方综合征患者接受开放性胸腹主动脉瘤修复术可获得相似的手术结局。
- 手术/围手术期策略必须根据每位患者的具体需求进行个体化调整以优化结局。
研究设计与样本
- 研究为连续性队列研究,纳入1997年至2022年接受胸腹主动脉瘤修复术的所有连续患者。
- 共684例患者接受开放性胸腹主动脉瘤修复术,其中马方综合征90例(13.1%),非马方综合征594例(86.9%)。
- 主要结局为主要不良事件的复合终点,次要结局为个别并发症和长期生存;采用逆概率治疗加权,加权Kaplan-Meier曲线估计长期生存,多变量分析识别与主要不良事件相关的因素。
主要发现
- 马方综合征患者较非马方综合征患者更年轻(46岁[范围36-56岁] vs 69岁[范围61-76岁];P<.001)。
- 马方综合征患者中Extent II或III型动脉瘤(57/90[63.3%] vs 211/594[35.6%];P<.001)及I或III型慢性夹层(77/90[85.3%] vs 242/594[40.8%];P<.001)更常见,心血管危险因素较少。
- 两组主要不良事件无差异(12/90[13.3%] vs 100/594[16.8%];P=.49),手术死亡率相似(3/90[3.3%] vs 28/594[4.7%];P=.75)。
- 未加权10年生存率为78.7% vs 46.8%(P=.001);加权Kaplan-Meier曲线显示长期生存无差异(校正风险比0.79;95%CI 0.32-1.99;P=.62;Log-rank P=.12)。
- 多变量分析中,肾功能不全(比值比2.29;95%CI 1.43-3.68;P<.01)和急诊/紧急手术(比值比2.17;95%CI 1.35-3.48;P<.01)与主要不良事件相关,马方综合征则无关(比值比1.56;95%CI 0.69-3.49;P=.28)。
临床怎么用
- 作者认为,开放性胸腹主动脉瘤修复术可在马方综合征与非马方综合征患者中实施并取得相似的手术结局。
- 作者建议,手术/围手术期策略必须针对每位患者的具体需求进行个体化调整以优化结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare operative and long-term outcomes between patients with and without Marfan syndrome undergoing thoracoabdominal aortic aneurysm repair. METHODS: We identified all consecutive patients undergoing thoracoabdominal aortic aneurysm repair between 1997 and 2022. Primary outcome was composite of major adverse events. Secondary outcomes were individual complications and long-term survival. Inverse probability of treatment weighting was performed. Weighted Kaplan-Meier curves were used to estimate long-term survival. Multivariable analysis identified factors associated with major adverse events. RESULTS: Six hundred eighty-four patients underwent open thoracoabdominal aortic aneurysm repair. Ninety (13.1%) had Marfan syndrome, whereas 594 (86.9%) did not. Marfan patients were younger (46 years [range, 36-56 years] vs 69 years [range, 61-76 years]; P < .001). Extent II or III aneurysms (57 out of 90 [63.3%] vs 211 out of 594 [35.6%]; P < .001) and type I or III chronic dissection (77 out of 90 [85.3%] vs 242 out of 594 [40.8%]; P < .001) were more common. Cardiovascular risk factors were less frequent in Marfan patients. There was no difference in major adverse events between groups (12 out of 90 [13.3%] vs 100 out of 594 [16.8%]; P = .49). Operative mortality was similar between groups (3 out of 90 [3.3%] vs 28 out of 594 [4.7%]; P = .75). Unweighted survival at 10 years was 78.7% vs 46.8% (P = .001). Weighted Kaplan-Meier curves showed no difference in long-term survival (adjusted hazard ratio, 0.79; 95% CI, 0.32-1.99; P = .62; Log-rank P = .12). At multivariable analysis, renal insufficiency (odds ratio, 2.29; 95% CI, 1.43-3.68; P < .01) and urgent/emergency procedure (odds ratio, 2.17; 95% CI, 1.35-3.48; P < .01) were associated with major adverse events, whereas Marfan syndrome was not (odds ratio, 1.56; 95% CI, 0.69-3.49; P = .28). CONCLUSIONS: Open thoracoabdominal aortic aneurysm repair can be performed with similar operative outcomes in patients with and without Marfan syndrome despite differing risk profiles. Operative/perioperative strategies must be tailored to specific needs of each patient to optimize outcomes.
引用
- Lau C, Soletti G, Weinsaft JW, et al. Risk profile and operative outcomes in patients with and without Marfan syndrome undergoing thoracoabdominal aortic aneurysm repair. J Thorac Cardiovasc Surg. 2023. PMID: 37164052. doi:10.1016/j.jtcvs.2023.03.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。